本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

1.02
0.0000
盤後1.01-0.0100-0.98%19:03 EST
成交量:16.14萬
成交額:16.50萬
市值:3,377.51萬
市盈率:-2.70
高:1.06
開:1.05
低:0.9906
收:1.02
52周最高:2.60
52周最低:0.6801
股本:3,311.28萬
流通股本:2,210.79萬
量比:1.05
換手率:0.73%
股息:- -
股息率:- -
每股收益(TTM):-0.3778
每股收益(LYR):-0.5489
淨資產收益率:-2478.16%
總資產收益率:-303.90%
市淨率:-65.08
市盈率(LYR):-1.86

資料載入中...

2025/08/15

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC問詢函

Form CORRESP - Correspondence
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/12/13

SEC問詢函

Form CORRESP - Correspondence
2024/12/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC問詢函

Form CORRESP - Correspondence
2024/05/20

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC問詢函

Form CORRESP - Correspondence
2023/09/01

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC問詢函

Form CORRESP - Correspondence
2023/08/15

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/14

SEC問詢函

Form CORRESP - Correspondence
2023/07/21

招股説明書

Form F-1 - Registration statement for certain foreign private issuers